PCNA and neoplasm: Recent studies also reveal that MSC-Exo can upregulate proliferating cell nuclear antigen (PCNA), activate the ERK1/2 signaling pathway, and accelerate angiogenesis, thereby supporting tumor development (Zhu et al. 2012).